Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
bioworld.com > articles > 732864-crispr-focused-scribe-goes-public-via-129m-ipo

CRISPR-focused Scribe goes public via $129M IPO | BioWorld

1+ day, 10+ hour ago   (18+ words) CRISPR-focused Scribe goes public via $129M IPO BioWorld News CRISPR-focused Scribe goes public via $129M IPO...

BioWorld News
bioworld.com > articles > 732866-sanofi-scraps-plans-for-amlitelimab-filings-in-atopic-dermatitis

Sanofi scraps plans for amlitelimab filings in atopic dermatitis

1+ day, 10+ hour ago   (91+ words) Sanofi SA will not seek approval of amlitelimab in atopic dermatitis (AD) as previously planned, stating that the OX40-ligand monoclonal antibody “would not represent a meaningful improvement to the standard of care” for patients with moderate to severe disease. The…...

BioWorld News
bioworld.com > articles > 732901-sprint-bioscience-to-use-lilly-tunelab-in-drug-development

Sprint Bioscience to use Lilly Tunelab in drug development

1+ day, 13+ hour ago   (20+ words) BioWorld News Sprint Bioscience to use Lilly Tunelab in drug development...

Google News
bioworld.com > articles > 732897-transcripta-bio-raises-funding-to-advance-neuro-pipeline

Transcripta Bio raises funding to advance neuro pipeline | BioWorld

1+ day, 13+ hour ago   (18+ words) Transcripta Bio raises funding to advance neuro pipeline BioWorld News Transcripta Bio raises funding to advance neuro pipeline...

BioWorld News
bioworld.com > articles > 732896-new-thyora-therapeutics-focuses-on-covalent-drug-discovery

New Thyora Therapeutics focuses on covalent drug discovery

1+ day, 13+ hour ago   (18+ words) BioWorld News New Thyora Therapeutics focuses on covalent drug discovery...

BioWorld News
bioworld.com > articles > 732910-antibody-drug-conjugates-reported-in-bioray-pharmaceutical-patent

Antibody-drug conjugates reported in Bioray Pharmaceutical patent

1+ day, 11+ hour ago   (18+ words) BioWorld News Antibody-drug conjugates reported in Bioray Pharmaceutical patent...

BioWorld News
bioworld.com > articles > 732907-zonsen-peplib-biotech-discloses-new-gpc3-targeting-peptide-drug-conjugates

Zonsen Peplib Biotech discloses new GPC3-targeting peptide-drug conjugates

1+ day, 11+ hour ago   (22+ words) BioWorld News Zonsen Peplib Biotech discloses new GPC3-targeting peptide-drug conjugates...

BioWorld News
bioworld.com > articles > 732908-hengrui-synthesizes-new-adcs-targeting-ceacam5

Hengrui synthesizes new ADCs targeting CEACAM5

1+ day, 13+ hour ago   (14+ words) BioWorld News Hengrui synthesizes new ADCs targeting CEACAM5...

BioWorld News
bioworld.com > articles > 732973-4d-nucleome-opens-new-wave-of-gene-regulation-research-discovery

4D Nucleome opens new wave of gene regulation research, discovery

1+ day, 11+ hour ago   (111+ words) After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA methylation regulate gene expression in health and disease. In a collection of eight papers…...

BioWorld News
bioworld.com > articles > 732852-lillys-triple-g-retatrutide-best-in-class-as-bla-filing-nears

Lilly’s triple-G retatrutide ‘best-in-class’ as BLA filing nears

2+ day, 5+ hour ago   (26+ words) BioWorld News Lilly’s triple-G retatrutide ‘best-in-class’ as BLA filing nears...